3.-IF1-mediated overexpression of Bcl-xL confers apoptotic resistance.
Introduction
The enhanced aerobic glycolysis of tumors (Cuezva et al., 2009; Vander Heiden et al., 2009 ) is a phenotypic trait acquired by cancer cells in their progression to malignancy (Hanahan and Weinberg, 2011; Hu et al., 2011) . The boost in glucose consumption is required to fuel the pentose phosphate and glycolytic pathways which provide the NADPH and metabolic intermediates needed as building blocks for the biosynthesis of nucleic acids, proteins and the phospholipids required for proliferation (Formentini et al., 2010; Frezza and Gottlieb, 2009) . Glutamine is also utilized by cancer cells to replenish with carbon skeletons the TCA cycle (Frezza and Gottlieb, 2009 ). In order to regenerate NAD + , aerobic glycolysis produces large amounts of lactate which is secreted from the cell to favor metastasis and angiogenesis (Gatenby and Gillies, 2004) . Several mechanisms directly promoting glycolysis, inhibition of mitochondrial function or both have been proposed, aiming to explain the metabolic hallmark of cancer cells and tumors (for review see (Cairns et al., 2011; Formentini et al., 2010; Frezza and Gottlieb, 2009) ). However, the mitochondrial contribution to the enhanced aerobic glycolysis of cancer cells has been questioned (Dang, 2010; Funes et al., 2007; Li et al., 2005) . In any case, some properties of cancer cells cannot be explained only by mutations. In fact, it is accepted that the tumor microenvironment (Cairns et al., 2011; Nyberg et al., 2008) and other epigenetic events (IacobuzioDonahue, 2009 ) contribute to cancer development and its behavior.
A master regulator of energetic metabolism is the mitochondrial H + -ATP synthase, a reversible engine of oxidative phosphorylation that catalyzes the synthesis of ATP using as driving force the proton gradient generated by the respiratory chain (Boyer, 1997) . Oxidative phosphorylation is also required for efficient execution of cell death (Dey and Moraes, 2000; Matsuyama et al., 1998; Santamaria et al., 2006) and cells that are unable to perform oxidative phosphorylation and rely heavily on aerobic glycolysis have an apoptotic-resistant phenotype (Dey and Moraes, 2000; Santamaria et al., 2006) . Conversely, activation of oxidative phosphorylation prevents tumor development (D'Errico et al., 2011; Schulz et al., 2006) . The catalytic β-F1-ATPase subunit of the H + -ATP synthase carries out the synthesis or hydrolysis of ATP upon changes in the physiological conditions of the cell. Genomic (Sheffer et al., 2009 ), transcriptomic (Lu et al., 2007 Sanchez-Arago et al., 2010) , proteomic (Cuezva et al., 2002; Cuezva et al., 2009 ) and functional studies (Holm et al., 1995; Lopez-Rios et al., 2007) in prevalent human carcinomas indicate that repressed bioenergetic activity of mitochondria is involved in tumor progression. Likewise, a lower bioenergetic activity of mitochondria is also linked to chemotherapy resistance (Li et al., 2010; Santamaria et al., 2006; Shin et al., 2005) . Masking the translation of β-F1-ATPase mRNA through the binding of specific mRNABPs onto the mRNA (Ortega et al., 2010) or by silencing of the ATP5B gene promoter (Li et al., 2010 ) is known to affect the mitochondrial content of β-F1-ATPase in human cancer. Moreover, metabolic reprogramming of tumors also encompass the inhibition of the H + -ATP synthase activity through the overexpression of the ATPase Inhibitory Factor 1 (IF1) (Sanchez-Cenizo et al., 2010) , which is a physiological inhibitor of the mitochondrial synthase.
The biological relevance of IF1 in human pathology is largely unknown (Campanella et al., 2008; Jennings et al., 1991) and specifically in the cancer field (Sanchez-Cenizo et al., 2010) . In this study, we have addressed the mechanisms and signaling pathway by which IF1 could participate in the biology of cancer cells.
Remarkably, we illustrate that a ROS-mediated retrograde response generated in mitochondria as a result of IF1 interference with oxidative phosphorylation switches on proliferation, invasion and cell survival. The IF1-mediated adaptive response of cancer cells is mediated by the activation of the canonical NFκB pathway.
Results

IF1
is overexpressed in colon cancer and regulates energy metabolism of HCT116 cells. As revealed by immunohistochemistry, and in agreement with previous findings (Sanchez-Cenizo et al., 2010) , IF1 is highly overexpressed in mitochondria (see punctuate cytoplasmic staining in right panel of Figure 1A ) of human colon carcinomas ( Figure 1A ) when compared to the normal tissue ( Figure 1B ). The overexpression of IF1 in HCT116 cells ( Figure 1C ) resulted in decreased oxidative phosphorylation (OSR) ( Figure 1D ), mitochondrial hyperpolarization ( Figure 1E ) and a concurrent enhancement of the rate of aerobic glycolysis ( Figure 1F ) in agreement with previous findings in other cells (Sanchez-Cenizo et al., 2010) . Likewise, siRNAmediated silencing of IF1 in HCT116 cells ( Figure 1C ) promoted an increase in oxidative phosphorylation ( Figure 1D ) and a reduction of the rates of aerobic glycolysis ( Figure 1F ) with marginal effect on the mitochondrial membrane potential (ΔΨm) ( Figure 1E ).
Basal cellular ATP concentrations were not affected by the regulated expression of IF1 ( Figure 1G ). However, the inhibitory effect of IF1 on the synthase activity of the H + -ATP synthase was further demonstrated by the significant drop in ATP content when aerobic glycolysis of the cells was inhibited with 2-deoxyglucose (2DG) in IF1 overexpressing cells ( Figure 1H ). Likewise, the silencing of IF1 promoted a relevant increase in ATP content when glycolysis was inhibited ( Figure 1H ). Treatment of the cells with oligomycin indicated that oxidative phosphorylation provides most of the ATP determined in the presence of 2DG ( Figure 1H ), thus supporting that the IF1-mediated changes in respiration are linked to the production of ATP by the H + -ATP synthase. These findings indicate that IF1 is used by cancer cells to inhibit the activity of H + -ATP synthase to favor the switch of energy metabolism toward aerobic glycolysis (Sanchez-Cenizo et al., 2010) .
IF1 regulates the rates of cellular proliferation and invasion. We studied the role of the expression level of IF1 in the rate of proliferation of HCT116 cells by assessing the incorporation of 5-ethynyl-2'-deoxyuridine (EdU) into DNA (Figure 2A ).
IF1 overexpression significantly augmented the rate of DNA replication when compared to control cells ( Figure 2A ). On the contrary, siRNA-mediated silencing of IF1 resulted in a lower rate of cellular proliferation when compared to control ( Figure 2A ).
Moreover, the over-expression of IF1 increased cell invasiveness when compared to controls ( Figure 2B ) whereas its silencing significantly reduced invasion ( Figure 2B ).
These results suggest a role for IF1 in switching on a mitochondrial retrograde signal to the nucleus (Butow and Avadhani, 2004) . Figure S2) . Moreover, we noted that the loss of AIF immunoreactivity in mitochondria after STS treatment was delayed in HCT116 cells overexpressing IF1 when compared to controls ( Figure 3B ).
Conversely, siRNA-mediated silencing of IF1 in HeLa cells accelerated the release of AIF after STS treatment ( Figure 3C ), supporting a role for IF1 in regulating mitochondrial-geared apoptosis ( Figure 3A) . Overall, the effects of IF1 overexpression on HCT116 cells mimicked the effects of oligomycin in delaying apoptosis (Matsuyama et al., 1998; Santamaria et al., 2006) Figure 1E ), promotes mitochondrial hyperpolarization due to the interruption of the backflow of H + into the matrix. In this situation, mitochondria produce the superoxide radical (Brand et al., 2004) .
Consistently, we observed that IF1 upregulation in HCT116 cells triggered a significant increase in the production of superoxide ( Figure 4A ). The mitochondrial scavenger MitoQ (MQ) (Kelso et al., 2001 ) was able to quench superoxide production in IF1 overexpressing cells ( Figure 4A ) as well as to ameliorate basal mitochondrial ROS levels in controls ( Figure 4A ).
One of the targets of oxygen radicals is the covalent modification of cellular proteins. Indeed, a significant increase in the carbonylation of specific cellular proteins was noted in HCT116 cells overexpressing IF1 when compared to controls ( Figure 4B and 4C). Remarkably, incubation of the cells with MQ diminished the IF1-triggered carbonylation of these proteins ( Figure 4B and 4C) . Interestingly, the overexpression of IF1 did not affect cellular hydrogen peroxide levels or the GSH/GSSG ratio (see Supplemental Figure S3 ) supporting that the IF1-mediated superoxide signal is of mild intensity and localized in mitochondria.
Cellular adaptive response to the regulated expression of IF1. IF1 was either overexpressed or silenced in HCT116 cells ( Figure 5A ) to study the expression of known targets of oxidative stress involved in the regulation of energy metabolism, apoptosis and proliferation (Klaunig and Kamendulis, 2004) . We did not find relevant changes in the content and/or in the phosphorylation status of the serine/threonine kinases Akt, c-Jun N-terminal kinase (JNK) and p38 kinase, which play important roles in adaptation to stress, inhibition of apoptosis and induction of proliferation (Cairns et al., 2011) . Likewise, the transcription factor HIF1α was not affected by IF1 expression ( Figure 5A ). Interestingly, overexpression of IF1 triggered the upregulation of the antiapoptotic Bcl-xL (Boise et al., 1993) (Figure 5A ) whereas silencing of IF1 mediated its downregulation ( Figure 5A ). The changes in Bcl-xL expression occurred in the absence of relevant changes in the cellular content of the pro-apoptotic Bax ( Figure 5A ). The transcription factor NFκB regulates a large number of genes related to inflammation, cell proliferation and apoptosis (Guha et al., 2010; Karin, 2006) and specifically Bcl-xL (Lee et al., 1999) . Therefore, we next studied the putative ROS-mediated activation of the NFκB signaling pathway in response to IF1 overexpression. Figure   5D ) and the concurrent reduction of its cellular content ( Figure 5D ). The incubation of the cells with the ROS scavenger MQ minimized IκBα phosphorylation and its downregulation ( Figure 5D ). Quenching the IF1-mediated ROS signal abolished transcriptional activation of Bcl-xL ( Figure 6B ) and the accumulation of Bcl-xL at both the protein ( Figure 6A ) and mRNA levels ( Figure 6C ). Interestingly, and consistent with the lack of changes in Bax content ( Figure 5A ), we observed no changes in Bax promoter activity by IF1 overexpression ( Figure 6D ), suggesting that the IF1-mediated resistance to cell death is accomplished by increasing the cellular content of Bcl-2 anti-apoptotic members.
Upregulation
ROS mediate transcriptional activation of
Mitochondrial ROS signaling links IF1 with proliferation and cell survival. To establish a link between IF1-mediated ROS production and cellular proliferation and the prevention of cell death, the effect of quenching the ROS signal was studied in proliferation ( Figure 7A ) and cell death after exposure to STS ( Figure 7B Figure S4) . Likewise, IF1 overexpression also triggered the ROS-dependent activation of NFκB, of cellular proliferation and ameliorated STS-induced cell death in SW620 cells (Supplemental Figure S4) .
Consistently, quenching the IF1-induced ROS signal with MQ reverted these effects (Supplemental Figure S4) , strongly supporting the essential role of IF1 in retrograde signaling the oncogenic phenotype in colon cancer.
Discussion
The switch from oxidative phosphorylation to glycolysis is a metabolic feature of proliferating cells. Consistently, human carcinomas show downregulation of the H + -ATP synthase concurrently with the induction of enzymes of glycolysis (Cuezva et al., 2002; Willers and Cuezva, 2011) . Moreover, carcinomas have an additional strategy to promote the metabolic switch required for proliferation that is mediated by upregulation of IF1 (Sanchez-Cenizo et al., 2010) . Indeed, here we show that IF1 overexpression in consequence of mitochondrial hyperpolarization is the production of superoxide radical (Brand et al., 2004) . Consistently, cancer cells are known to have higher basal levels of ROS (Szatrowski and Nathan, 1991) . In agreement with these findings, we have observed that the overexpression of IF1 triggers mitochondrial hyperpolarization, a higher basal production of superoxide radical as well as increased carbonylation of cellular proteins. Therefore, we suggest that the high ΔΨm and ROS levels observed in cancer cells most likely result from the IF1-mediated inhibition of the H + -ATP synthase due to the high expression level of IF1 observed in most cancer cells (Sanchez-Cenizo et al., 2010) . In this regard, it has been shown that IEX-1, a stress-inducible gene involved in IF1 degradation, also suppresses the production of reactive oxygen species (Shen et al., 2009) .
Previous studies have shown in carcinomas with mutations in mtDNA or in Kras (Ishikawa et al., 2008; Weinberg et al., 2010 ) that an enhanced mitochondrial activity is required to generate the ROS involved in tumorigenicity. In contrast, the ROS-mediated oncogenic function of IF1 is exerted by inhibition of the H + -ATP synthase and thus by restraining the bioenergetic activity of mitochondria. Since IF1 is highly up-regulated in breast, colon and lung carcinomas ((Sanchez-Cenizo et al., 2010) and unpublished data) it is likely that its mechanism of action could be generalized to all these tumors. We suggest, in light of recent findings (Mullen et al., 2011) , that carcinomas with IF1-limited oxidative phosphorylation could also have glutamine-dependent reductive carboxylation as a major pathway for citrate formation. HIF1α expression supports the idea that mitochondrial ROS signaling might activate a cellular adaptation program unrelated to the hypoxia associated pathway (Weinberg et al., 2010) . We believe that sustained retrograde ROS signaling by mitochondrial hyperpolarization in non-hypoxic conditions explains the adaptive phenotype of cells overexpressing IF1. Indeed, we show that quenching the mitochondrial production of superoxide radical prevented both the proliferative and pro-survival activities of IF1.
The effect of ROS on cell fate depends on the level at which ROS are present . Interestingly, the ROS-mediated activation of the NFκB pathway triggered by IF1 appears not to correlate with the induction of the antioxidant defense because we observed a higher basal level of oxidation of cellular proteins, suggesting that the ROS-signaling event is of moderate intensity and able to promote proliferation and survival. Consistent with a mild IF1-mediated ROS signal, we observe no relevant changes in cellular hydrogen peroxide content and in the GSH/GSSG ratio. These observations suggests that cancer cells have additional strategies to overcome the effects of excessive ROS signaling, which might be related to the expression of uncoupling proteins in their mitochondria (Brand et al., 2004) .
The transcription factor NFκB has emerged as a crucial regulator of cellular adaptive responses involving proliferation and survival (Karin, 2006) . The NFκB pathway is also involved in the regulation of the immune response (Vesely et al., 2011) and in some situations promotes the activation of mitochondrial respiration (Mauro et al., 2011) . Alterations in these activities contribute to cancer development and progression. ROS can interact with NFκB at various places within its signaling pathway (Morgan and Liu, 2011) . One main pathway that cross-talks with NFκB and ROS is JNK. However, we observed no discernible changes in JNK at both the protein and mRNA levels as well as in the extent of phosphorylation of the kinase. It has been argued that mitochondrial retrograde signaling regulates both the canonical and noncanonical NFκB pathways (Guha et al., 2010) . Our data demonstrate that IF1 mediates the activation of the canonical pathway because we observe the phosphorylation and cellular reduction of the repressor IκBα. Moreover, we show that quenching mitochondrial ROS production abolished NFκB activation by preventing IκBα phosphorylation and degradation.
It is well established that oxidative phosphorylation is required for efficient execution of cell death (Dey and Moraes, 2000; Matsuyama et al., 1998; Santamaria et al., 2006) . In fact, the inhibition of the activity of the H The IF1-mediated activation of NFκB promotes the expression of anti-apoptotic genes such as Bcl-xL, which is an additional strategy of the tumor cell to evade immunosurveillance (Vesely et al., 2011) . Accordingly, IF1 signaling to the NFκB pathway promoted the repression of the expression of genes involved in the innate immune response ( Figure 5 ). Likewise, IF1-mediated NFκB activation was observed to lead to the upregulation of mitogenic genes and genes involved in proliferation and tumor invasion ( Figure 5 ). Thus, IF1-signaling to the nucleus promotes the activation of multiples pathways for the perpetuation of the cancer cell. Therefore, IF1 could be envisioned as the molecular switch in the cancer cell that turns mitochondrial activity from a tumor suppressor into a tumor promoter.
The number of cancers related with genetic alterations of mitochondria are very limited (Frezza and Gottlieb, 2009) . However, the impact of cancer genes in energy metabolism has been amply demonstrated (Cuezva et al., 2009; Hu et al., 2011; Li et al., 2005; Vander Heiden et al., 2009) . Although the role of mitochondrial activity in cancer cells has been questioned (Dang, 2010; Funes et al., 2007; Li et al., 2005 ) the study of large cohorts of most prevalent human carcinomas sustain the alteration of the bioenergetic function of mitochondria (Cuezva et al., 2002; Cuezva et al., 2009; LopezRios et al., 2007) . We should emphasize that mitochondrial dysfunction in tumors is not "irreversible" (Michelakis et al., 2008; Sanchez-Arago et al., 2010) because energy metabolism depends on many factors that could influence at short-or long-term the activity of the enzymes involved (Formentini et al., 2010) . The over-expression of IF1 in human carcinomas is an additional epigenetic factor that contributes to the peculiar energy metabolism of mitochondria in cancer. In fact, IF1 directly promotes the acquisition of three hallmarks of the cancer phenotype: (i) the switch in energetic metabolism, (ii) increased proliferation and invasion and (iii) the evasion of cell death ( Figure 7D ). We suggest that studies aimed at characterizing the regulation of IF1 expression will provide profitable targets for therapeutic intervention. 
Experimental Procedures
